Search

Your search keyword '"Andrews, Jane M."' showing total 1,052 results

Search Constraints

Start Over You searched for: Author "Andrews, Jane M." Remove constraint Author: "Andrews, Jane M."
1,052 results on '"Andrews, Jane M."'

Search Results

5. Efficacy and safety of 48 weeks of guselkumab for patients with Crohn's disease: maintenance results from the phase 2, randomised, double-blind GALAXI-1 trial

7. Reliability of Intestinal Ultrasound for Evaluating Crohn’s Disease Activity Using Point-of-care and Central Reading

10. HLA-DP on Epithelial Cells Enables Tissue Damage by NKp44+ Natural Killer Cells in Ulcerative Colitis

11. The cost of inflammatory bowel disease in high-income settings: a Lancet Gastroenterology & Hepatology Commission

12. Efficacy and safety of gluten peptide-based antigen-specific immunotherapy (Nexvax2) in adults with coeliac disease after bolus exposure to gluten (RESET CeD): an interim analysis of a terminated randomised, double-blind, placebo-controlled phase 2 study

14. Guselkumab for the Treatment of Crohn’s Disease: Induction Results From the Phase 2 GALAXI-1 Study

15. EFFICACY AND SAFETY OF GUSELKUMAB THERAPY IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN’S DISEASE: RESULTS OF THE GALAXI 2 G 3 PHASE 3 STUDIES

18. Depression influences fatigue in inflammatory bowel disease amongst other factors: a structural modelling approach.

19. Efficacy and safety of 48 weeks of guselkumab for patients with Crohn's disease: maintenance results from the phase 2, randomised, double-blind GALAXI-1 trial

23. High Technical Success Rate of Endoscopic Balloon Dilatation Reduces Surgical Requirement for Patients With Stricturing Crohn’s Disease

26. Host–microbe interactions have shaped the genetic architecture of inflammatory bowel disease

27. A Web-Based Decision Aid (myAID) to Enhance Quality of Life, Empowerment, Decision Making, and Disease Control for Patients With Ulcerative Colitis: Protocol for a Cluster Randomized Controlled Trial

29. Epitope-specific immunotherapy targeting CD4-positive T cells in coeliac disease: two randomised, double-blind, placebo-controlled phase 1 studies

30. Factors associated with progression or non‐progression to bariatric surgery in adults: A systematic review.

33. Efficacy and safety of gluten peptide-based antigen-specific immunotherapy (Nexvax2) in adults with coeliac disease after bolus exposure to gluten (RESET CeD): an interim analysis of a terminated randomised, double-blind, placebo-controlled phase 2 study

34. Concentrations of Adalimumab and Infliximab in Mothers and Newborns, and Effects on Infection

35. A Method to Exploit the Structure of Genetic Ancestry Space to Enhance Case-Control Studies

37. Inherited determinants of Crohn's disease and ulcerative colitis phenotypes: a genetic association study

38. Anti-TNF Therapy in Pregnant Women With Inflammatory Bowel Disease: Effects of Therapeutic Strategies on Disease Behavior and Birth Outcomes

40. Insomnia is common in inflammatory bowel disease (IBD) and is associated with mental health conditions as well as IBD activity.

46. Measurement of Fecal Calprotectin Improves Monitoring and Detection of Recurrence of Crohn's Disease After Surgery

47. Crohn's disease management after intestinal resection: a randomised trial

Catalog

Books, media, physical & digital resources